Prof. Marcy Zenobi-Wong is a Full Professor at ETH Zurich's Department of Health Sciences and Technology, specializing in biofabrication and tissue engineering. Her research focuses on cartilage regeneration using advanced biomaterials, including nanofilm coatings and 3D printing techniques. She holds patents in tissue engineering and has pioneered methods like filamented light (FLight) biofabrication for creating anisotropic tissues. Her academic journey includes a B.Sc. from MIT (1985), M.Sc. and Ph.D. from Stanford (1987, 1990), followed by postdoctoral work at the University of Michigan. She leads the Biofabrication Group at ETH, developing therapies for joint repair and regenerative medicine. Courses taught include Biomedical Engineering and Materials and Mechanics in Medicine . Research highlights include engineered hydrogels for cartilage protection, CRISPR-driven gene editing in chondrocytes, and biohybrid neural interfaces. Her work bridges material science, cell biology, and clinical applications, with a focus on translational medicine. Collaborative projects involve creating elastic cartilage grafts for microtia reconstruction and volumetric printing of complex tissue constructs.
Bradley D. Olsen is a full professor in the Department of Chemical Engineering at the Massachusetts Institute of Technology (MIT), where he leads research at the intersection of polymer science, soft matter physics, and bioengineering. His work focuses on designing materials for critical applications in biotechnology, hemostasis, and sustainable polymer development while advancing fundamental understanding of polymer network mechanics and self-assembly. Education: Ph.D. in Chemical Engineering, University of California Berkeley (2007) S.B. in Chemical Engineering, Massachusetts Institute of Technology (2003) Olsen's research spans protein-based materials, block copolymer phase behavior, and mechanochemical hydrogels. He has pioneered methods for quantifying polymer network topology, developing hemostatic nanoparticles, and creating bio-inspired materials for selective biomolecular transport and medical applications. His recent publications emphasize data-driven approaches to polymer characterization and educational outreach in materials science. Scientific Awards: American Physical Society (APS) Fellow (2023) Fulbright Amazonia Scholar (2023) Alexander and I. Michael Kasser Chair in Chemical Engineering (2021) ACS Macro Letters Young Investigator Award (2021) MIT Committed to Caring Honor (2019) AIChE Owens Corning Early Career Award (2019) APS Dillon Medal (2018) Kavli Emerging Leader in Chemistry (2017) ACS Polymer Division Fellow (2016) Camille Dreyfus-Teacher Scholar (2015) Alfred P. Sloan Research Fellow (2014) NSF Career Grant (2013) NIH Postdoctoral Fellowship (2008-2009) Hertz Fellow (2003-2007) Barry M. Goldwater Scholarship (2002) Olsen has received significant grant support including NSF Career (2013) and AFOSR (2012) awards. His teaching activities include innovative international outreach like the 2025 soccer-themed science camp in Brazil. The Olsen Group at MIT explores advanced materials with applications ranging from trauma care to sustainable polymers.
Rebecca Schulman is an Associate Professor in the Department of Chemical and Biomolecular Engineering at the Whiting School of Engineering, Johns Hopkins University. She holds secondary appointments in Chemistry and Computer Science and is affiliated with multiple interdisciplinary institutes, including the Institute for NanoBioTechnology, the Hopkins Extreme Materials Institute, the Chemistry-Biology Interface Program, the Center for Cell Dynamics, and the Laboratory for Computational Sensing and Robotics. She currently co-directs the Passport to Future Technology Leadership program for PhD students. Research Interests: Schulman's research lies at the intersection of DNA nanotechnology, synthetic biology, and smart materials. Her group develops intelligent, adaptive biomolecular materials and nanostructures by integrating concepts from materials science, biochemistry, circuit design, and soft matter physics. The team focuses on engineering dynamic self-assembly processes using DNA to create reconfigurable materials, molecular circuits, and autonomous soft micro-robots. Key themes include self-healing nanostructures, feedback-regulated crystallization, programmable hydrogels, and synthetic genetic networks for materials control. Publication Trends: Her recent publications demonstrate a consistent focus on using DNA-based chemical reaction networks to program spatial and temporal behavior in materials. The work spans from fundamental mechanisms like catalytic polymerization and crystal growth regulation to applications in soft robotics, self-wiring circuits, and synthetic pattern formation. The research is highly interdisciplinary, combining synthetic biology with materials engineering to achieve life-like functionalities in non-living systems. Scientific Awards: AIMBE Fellowship Award Vannevar Bush Faculty Fellowship Award Hartwell Individual Biomolecular Research Award President’s Early Career Award in Science and Engineering (PECASE) DARPA Young Faculty Award DARPA Directors Fellowship NSF CAREER Award Turing Scholar Award DOE Early Career Award Advising and Grants: Schulman mentors graduate students and leads a vibrant research group focused on next-generation biomolecular engineering. Her work is supported by major federal grants, including the NSF CAREER, DOE Early Career, DARPA, and the Vannevar Bush Fellowship—a prestigious Department of Defense award for basic research. She is actively involved in training future leaders through programs like the Passport to Future Technology Leadership. Labs and Teams: The Schulman Lab at Johns Hopkins is a multidisciplinary team working on DNA-powered materials and molecular programming. The lab is embedded within several collaborative centers, enabling strong cross-departmental and cross-institutional research. Their work combines experimental biochemistry with theoretical modeling to design and implement complex molecular systems.
Judith Driscoll is Professor of Materials Science at the University of Cambridge in the Department of Materials Science & Metallurgy. She holds the prestigious Royal Academy of Engineering Chair in Emerging Technologies and serves as a Visiting Staff Member at Los Alamos National Laboratory. As the founding Editor-in-Chief of APL Materials, she has significantly contributed to the materials science community. Dr. Driscoll's research focuses on Energy Efficient Oxide Materials for Information and Communications Technologies and energy devices. Her work spans the development of non-volatile memory, resistive switching devices, and ferroelectric materials for neuromorphic computing applications. She investigates oxide thin films for applications ranging from data storage to energy generation and conversion, with particular emphasis on creating more energy-efficient device technologies to handle the exponential growth of data-centric applications. Her recent publications demonstrate strong trends in developing novel oxide-based memory devices with improved energy efficiency, particularly for AI applications. The work shows significant progress in hafnium-zirconium oxide ferroelectrics, resistive switching mechanisms, and vertically aligned nanocomposite structures for enhanced device performance. These innovations address critical challenges in reducing the unsustainable energy demands of modern computing, particularly for artificial intelligence systems. Fellow of the Royal Academy of Engineering Fellow of the Materials Research Society Fellow of the American Physical Society Fellow of IOM3, IOP, and Women Engineers Society Fellow of the American Academy of Arts and Sciences Recipient of ERC Advanced Grant Editor-in-Chief of APL Materials Dr. Driscoll leads a vibrant research group that has secured significant funding including her Royal Academy of Engineering Research Chair, an ERC Advanced Grant, and an ECCS-EPSRC grant in collaboration with researchers from the USA. She has founded the Cambridge Centre for Neuromorphic Computing (Neucam) in 2023. Her group operates world-leading growth equipment including pulsed laser deposition with RHEED control, high temperature oxide sputtering, and spatial ALD systems. She collaborates extensively across the University of Cambridge and with international partners to solve complex materials challenges, with her group's role often being to identify optimal materials for functional goals, predict fabrication methods, and then create and characterize these materials.
Prof. Raffaele Mezzenga is a Full Professor at ETH Zürich's Department of Health Sciences and Technology and Head of the Institute of Food, Nutrition, and Health. He earned his master's from Perugia University (Italy) and a PhD in Polymer Physics from EPFL, followed by postdoctoral work at UC Santa Barbara. His career includes roles at the Nestlé Research Center and the University of Fribourg before joining ETH in 2009. His research focuses on self-assembly processes in polymers, biopolymers, and colloidal systems, with applications in environmental remediation, bioplastics, and biomedical materials. Key contributions include pioneering protein-based materials and advancing understanding of amyloid fibrils. Education: Master's, Materials Science & Engineering, Perugia University PhD, Polymer Physics, EPFL Research Interests: Self-assembly, biopolymers, amyloid materials, sustainable technologies, food colloids, and soft condensed matter. Awards: 2011 AOCS Award, 2017 APS Fellowship, and 2013 Biomacromolecules Young Investigator Award. Visiting Roles: Held visiting professorships at Aalto University, RMIT, Monash University, Nanyang Technological University, and others. Labs/Teams: Leads the Institute of Food, Nutrition, and Health at ETH, focusing on interdisciplinary research in food science and biomaterials. His work bridges fundamental science and applied innovation, addressing global challenges in sustainability and health through materials science. Recent projects include creating bioplastics from food waste, developing amyloid-based water purification systems, and advancing targeted drug delivery via lipidic mesophases.
Masato Kato serves as Professor in the Department of Biochemistry at the University of Texas Southwestern Medical Center since 2020 and concurrently as Team Leader at Japan's National Institutes for Quantum and Radiological Science and Technology. His academic trajectory includes progressive appointments from Assistant Professor (2004-2014) to Associate Professor (2014-2020) at UT Southwestern, with prior postdoctoral training at Harvard Medical School and Nara Institute of Science and Technology. 2020-present: Professor, Department of Biochemistry, UT Southwestern 2020-present: Team Leader, National Institutes for Quantum and Radiological Science and Technology, Japan 2014-2020: Associate Professor, Department of Biochemistry, UT Southwestern 2010-2014: Assistant Professor, Department of Biochemistry and Internal Medicine, UT Southwestern 2004-2010: Assistant Professor, Department of Internal Medicine, UT Southwestern 1999-2004: Postdoctoral Fellow, Ellenberger Lab, Harvard Medical School 1998-1999: Postdoctoral Fellow, Hakoshima Lab, Nara Institute of Science and Technology Dr. Kato's research pioneers the biophysical characterization of protein phase separation, particularly focusing on low-complexity domains (LCDs) in neurodegenerative disease contexts. His work establishes fundamental mechanisms of biomolecular condensate formation, including hydrogel polymerization, liquid-solid transitions, and mutation-induced dysregulation in ALS/FTD. Key contributions demonstrate how C9orf72-encoded poly-dipeptides disrupt nucleocytoplasmic transport and how redox states regulate Ataxin-2 phase behavior, bridging structural biochemistry with pathological mechanisms. Analysis of his 22 publications reveals a cohesive research program centered on LCD-driven phase transitions. The most recent 15 articles (2012-2019) systematically investigate pathological aggregation in neurodegeneration, structural basis of condensate formation, and regulatory mechanisms like phosphorylation and oxidation. This body of work establishes LCDs as central players in both physiological RNA granule assembly and disease-associated solidification, with strong emphasis on C9orf72-related ALS/FTD mechanisms. Dr. Kato maintains active leadership within the McKnight Laboratory at UT Southwestern, where his team employs integrated approaches spanning structural biology, cell biology, and biophysics to dissect phase separation mechanisms. His collaborative network includes prominent neuroscience and biochemistry groups, with co-authorship on key studies in Cell, Science, and PNAS.
Prof. Dr. Stefan Luther is a Max Planck Research Group leader (W2, tenured since 2013) at the Max Planck Institute for Dynamics and Self-Organization, Göttingen, and an Honorarprofessor at the Faculty of Physics, University of Göttingen. He holds adjunct roles as Adjunct Associate Professor at Cornell University (2009–2012) and Northeastern University (2016–2018), and serves as DZHK-Professor at the Institute of Pharmacology and Toxicology, University Medical Center Göttingen. His research focuses on nonlinear spatiotemporal dynamics in excitable biological media, particularly cardiac arrhythmias. He pioneered 4D imaging of heart function and developed algorithms for optogenetic and electrical control of arrhythmias. Translational efforts span basic research to preclinical and clinical studies. Education includes a Diplom in Physics (1997) and PhD (2000) from Georg-August-University, Göttingen. Postdoctoral training followed at the University of Twente (2001–2004) and Cornell University’s LASSP (2004–2006). His lab, the Biomedical Physics group, explores electromechanical coupling in cardiac systems and develops novel therapeutic approaches. Collaborations include work on computational modeling, uncertainty quantification in dynamical systems, and fluid dynamics of multiphase flows.
Elisabeth Prince is an Assistant Professor at the University of Waterloo, specializing in polymer chemistry and biomaterials. Her research focuses on developing advanced materials for biomedical applications, sustainable materials, and microfluidic technologies. Key areas include conductive hydrogels, cleavable polymers for recyclability, and biomimetic systems for drug delivery and cancer therapy. Her work bridges disciplines such as materials science, nanotechnology, and biomedical engineering. Recent studies involve applications in strain-stiffening hydrogels, filamentous aerogels for electromagnetic shielding, and microfluidic platforms for organoid production. These innovations aim to address challenges in regenerative medicine, environmental sustainability, and personalized cancer treatments. No scientific awards are listed in the provided materials. Research activities include collaborations on 3D-printed microfluidic devices and nanofibrillar hydrogels mimicking biological systems. No advising relationships or grants are explicitly mentioned in the text.
James Shorter is a Professor of Biochemistry and Biophysics at the Perelman School of Medicine, University of Pennsylvania. He is affiliated with multiple prestigious institutes, including the Institute on Aging (IOA), the Institute for Translational Medicine and Therapeutics (ITMAT), the Penn Center for AIDS Research (CFAR), the Chemistry-Biology Interface (CBI), and the Penn Institute for RNA Innovation. He mentors several training programs such as the Penn Summer Undergraduate Internship Program (SUIP), PennPREP, and the Translational Research Immersion Program (TRIP), and serves as a Primary Trainer at the Center for Neurodegenerative Research (CNDR). Ph.D. in Cell Biology, University of London, 2000 M.A. in Biology, University of Oxford, 1995 Dr. Shorter’s research focuses on protein homeostasis, particularly the mechanisms of protein disaggregation and the role of prion-like domains in neurodegenerative diseases such as ALS, Alzheimer’s, Parkinson’s, and frontotemporal lobar degeneration. His lab investigates the Hsp104 disaggregase from yeast and has engineered variants to combat human proteinopathies. They also identified the mammalian disaggregase system (Hsp110/Hsp70/Hsp40) and explore how small molecules and nuclear import receptors can reverse pathological phase transitions of RNA-binding proteins like TDP-43 and FUS. His work bridges structural biology, genetics, and translational neuroscience. His recent publications highlight trends in targeting TDP-43 and FUS proteinopathies, engineering Hsp104 for selective detoxification, understanding mitochondrial disaggregases like Skd3, and modulating phase transitions with nuclear import receptors. His research spans from fundamental mechanisms of protein folding to therapeutic development for neurodegenerative diseases. Faculty Member, Institute on Aging (IOA) Faculty Member, Institute for Translational Medicine and Therapeutics (ITMAT) Mentor, Penn Summer Undergraduate Internship Program (SUIP) Primary Trainer, Center for Neurodegenerative Research (CNDR) Faculty Member, Penn Center for AIDS Research (CFAR) Member, Penn Institute for RNA Innovation Mentor, Translational Research Immersion Program (TRIP) Dr. Shorter advises numerous graduate students and postdoctoral researchers through the Biochemistry and Molecular Biophysics, Pharmacology, Neuroscience, and Cell and Molecular Biology graduate groups. His lab receives funding from NIH and other sources to support research on protein disaggregation, phase separation, and neurodegenerative disease mechanisms. He has trained many scientists now active in academia and biotech. His lab, located in Stellar-Chance Laboratories, operates at the intersection of biochemistry, cell biology, and translational medicine, with active projects on Hsp104 engineering, mitochondrial proteostasis, and the role of RNA-binding proteins in disease. The lab collaborates widely across Penn and with international partners to advance understanding and treatment of protein misfolding disorders.
Jozef Vleugels is a full Professor at KU Leuven's Faculty of Engineering Sciences, where he serves as Department Head of Functional Materials (SIEM) within the Department of Materials Science. He is also Chairman of the Leuven Centre for Materials and serves as contact person for the Functional Materials research unit located at Castle Park Arenberg 44 in Leuven. His research focuses on advanced materials processing, particularly in ceramics, powder metallurgy, and additive manufacturing. Vleugels has extensive expertise in zirconia-based dental biomaterials, nuclear materials, and refractory ceramics. His work integrates traditional ceramic processing techniques with cutting-edge additive manufacturing technologies, including direct ink writing (DIW) and binder jetting for complex geometries. His recent publications demonstrate a strong emphasis on dental applications of zirconia ceramics, laser surface modification techniques, microwave processing, and high-entropy carbide systems. His research group is actively involved in numerous EU and national projects related to additive manufacturing of multi-material components, nuclear applications, and dental biomaterials. Prof. Vleugels teaches several courses including Ceramics and Powder Metallurgy, Advanced Ceramic Materials, and project-based courses in materials science. He supervises numerous doctoral candidates and collaborates extensively with industry partners on applied research projects. He is an active member of multiple research networks including the Materials Science Division, KIEM – KU Leuven Institute for Energy and Society, and Leuven.AM – KU Leuven Institute for Additive Manufacturing. He also serves on various faculty and departmental councils including the Faculty Council of Engineering Sciences and the Departmental Council of Materials Science.
Prof. Andreas Bausch holds the Heinz Nixdorf Endowed Chair of Cell Biophysics at the Technical University of Munich (TUM) within the TUM School of Natural Sciences . His research focuses on cellular biophysics , particularly the mechanical properties of cytoskeletal networks and self-organization mechanisms in biological systems, with applications in biomimetic materials and organoid modeling. Research Areas : Cytoskeletal mechanics, active matter systems, organoid morphogenesis, integrin signaling, synthetic cell models Techniques : Microrheology, in vitro reconstitution, microfluidics, advanced imaging His work has produced over 100 publications in Nature, Science, PNAS , and Physical Review Letters , with recent emphasis on pancreatic cancer organoids and artificial cell membranes . Key findings include: Discovery of topological excitations governing endothelial cell ordering Elucidation of PIP2/PIP3 regulation in integrin phase separation Development of 3D patterned organoid systems for drug screening Major awards include: ERC Synergy Grant (2018) ERC Advanced Grant (2012) ERC Starting Grant (2011) Berlin-Brandenburg Academy of Sciences Prize (2014) He serves as founding director of the Center for Functional Protein Assemblies (CPA) since 2015 and teaches biomechanics , biophysics , and protein assemblies at TUM. His lab investigates both fundamental biophysical principles and their medical applications in cancer and cardiovascular systems.
Aji Mathew is a Professor at the Department of Materials and Environmental Chemistry, Stockholm University. He holds a PhD in polymer chemistry from Mahatma Gandhi University (2001) and conducted postdoctoral research at CERMAV (Grenoble, France) and NTNU (Trondheim, Norway). His academic career includes roles as an assistant professor (2007–2011) and associate professor (2011–2015) at Luleå University of Technology before becoming an associate professor (2015) and subsequently a professor (2017) at Stockholm University. His research focuses on bio-based nanocomposites and sustainable materials, particularly nanocellulose and its applications in environmental remediation, advanced materials, and circular economy solutions. His group, the Aji Mathew Group , specializes in designing bio-based materials for diverse applications, including water treatment, 3D printing, and biomedical uses. Key projects involve upcycling textile waste, developing eco-friendly composites, and creating functional hydrogels. His work bridges fundamental polymer chemistry with practical sustainability challenges. Publications highlight innovations like nanocellulose-based foams, zeolitic frameworks for water purification, and bio-based coatings. While no awards are explicitly mentioned, his extensive peer-reviewed contributions reflect significant scholarly impact. His research emphasizes scalability and real-world applicability, addressing global environmental and material science challenges.
Ferran Garcia-Pichel is a Regents Professor and Center Director at Arizona State University’s School of Life Sciences, affiliated with the Biodesign Center for Fundamental & Applied Microbiomics, Center for Biodiversity Outcomes, Water Institute, and Global Drylands Center. He holds a PhD in Microbiology from the University of Oregon (1999) and has been a faculty member at ASU since 1999. His research focuses on microbial adaptations in arid environments, including biogeochemical cycling, soil crust formation, and sustainable land restoration. Key interests include cyanobacterial sunscreen compounds (scytonemin), carbonate dissolution mechanisms, and hydrogen production. Teaching responsibilities include advanced microbiology, microbial ecology, and geomicrobiology courses such as MBB 495 Undergraduate Research and BIO 493 Honors Thesis. Awards span from the 2021 Regents Professor distinction to the 2023 Sperry Award for restoration science. His lab explores interdisciplinary approaches to study microbial communities in desert soils, marine intertidals, and atmospheric dust, with applications in climate resilience and biomedicine. Research highlights include biocrust restoration strategies, microbial nitrogen fixation networks, and the role of GABA/Glu signaling in spatial organization. Collaborations address global challenges like fugitive dust mitigation and carbon sequestration. The lab is based at the Biodesign Building B on ASU’s Tempe campus.
Sarah Köster is a Full Professor at the University of Göttingen’s Institute for Cellular and Molecular Physiology of the Brain. She earned her PhD from the University of Göttingen under Prof. Stephan Herminghaus and completed postdoctoral research at Harvard University with Prof. David Weitz. Her career includes appointments as Junior Professor (2008-2011), Associate Professor (2011-2017), and Full Professor (since 2017). Research focuses on cellular biophysics, particularly cytoskeletal mechanics and intermediate filament dynamics. Key investigations include keratin plasticity, vimentin network mechanics, cytoskeletal crosstalk, and DNA organization during cell division. Her publications demonstrate expertise in nanoscale biomechanics, utilizing techniques like nanoindentation, X-ray diffraction, and advanced microscopy to probe cellular structures. Recent work emphasizes multiscale mechanical properties of cytoskeletal networks and their functional implications.
Stephen L. Bearne is a Professor in the Departments of Biochemistry and Molecular Biology and Chemistry at Dalhousie University, affiliated with the Faculty of Medicine. He has been a department member since 1996 and served as Department Head from 2012 to 2022. His research focuses on enzymology, enzyme catalysis, and protein engineering, with a particular emphasis on transition state analogues, enzyme inhibition mechanisms, and the chemical basis of disease-associated enzymes. His work integrates organic synthesis, biophysical techniques, and computational modeling to explore enzyme function and design inhibitors for therapeutic applications. Dr. Bearne holds a PhD from the University of Toronto and an MDCM from McGill University. His lab is part of the Protein Assembly Research Team and the BioActives CREATE Training Program. Current research themes include understanding carbon acid substrate catalysis in mandelate racemase, developing inhibitors for CTP synthase and racemases involved in diseases like cancer and neglected tropical infections, and proteomic tools for enzymatic activity profiling. His research leverages advanced techniques such as site-directed mutagenesis, isothermal titration calorimetry, NMR spectroscopy, and macroion mobility spectrometry. His lab supports equity, diversity, and inclusivity and has been funded by NSERC, CIHR, and other agencies. Recent publications highlight advancements in enzyme inhibition strategies, allosteric regulation mechanisms, and enzyme filamentation roles in metabolic pathways.
